NIH-funded research R01 grant

Elucidating how calcineurin signaling drives pancreatitis and identifying new targets

Official title: Elucidating novel mechanisms for pancreatitis through calcineurin signaling

Funded at Stanford University · NIH-11367438 · Data updated 2026-11-12

This NIH grant looks at how a signaling protein called calcineurin contributes to acute pancreatitis and aims to find new ways to block it so patients have milder symptoms.

More Pancreatitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startAugust 1, 2024
Project endMay 31, 2028
Funding year2026
Award (this year)$606,814
NIH project number5R01DK140433-03
Project IDNIH-11367438 on NIH RePORTER

Who could benefit from this research

Could help

Patients with or at risk for acute pancreatitis who could benefit from new targeted therapies emerging from this research.

Less likely to help

Those with pancreatitis complications not driven by calcineurin signaling or who are not eligible for future targeted trials may see no direct benefit.

What this research studies

People with acute pancreatitis experience severe pain and illness, and current treatments are limited. This project will map the signaling networks that calcineurin controls in pancreatic acinar cells during pancreatitis and use advanced phosphoproteomics and bioinformatics to find CN-driven pathways. It will also study how CN affects mTOR and autophagy processes, which are important for cell health, during pancreatitis. Finally, researchers will test candidate CN substrates to identify potential therapeutic targets for more precise treatment.

Why it matters

Potential benefit: Identification of new targets could lead to therapies that reduce pancreatitis severity and improve recovery for patients.

How similar studies have gone: Prior phosphoproteomic and signaling studies have revealed meaningful pathways in pancreatitis, supporting a similar approach here.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Husain, Sohail Z — Stanford University
  • Study coordinator: Husain, Sohail Z

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.